Loading
Everything OnCo dates to 1956: 8 entries, 4 landmarks, 1 approval, 1 company founded and 1 paper. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
8 dated entries in OnCo fall in 1956: 4 landmarks, 1 approval, 1 company founded, 1 paper and 1 technology.
Of those, 8 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Palliation of androgen-responsive advanced breast cancer in postmenopausal women (historic label)
The publication year on key paper records.
WARBURG O. Science.
The history entries editors wrote on cancer records: the dated turning points of each disease.
Wilms tumour (nephroblastoma). Combined with surgery and radiation, cure rates begin to climb.
Gestational trophoblastic neoplasia. The first solid tumour cured by chemotherapy.
High-risk gestational trophoblastic neoplasia (FIGO score 7 or more, including ultra-high-risk)
Low-risk gestational trophoblastic neoplasia (FIGO score 0 to 6)
The since year on technology records: first use in humans or first approval, as the record states it.
First use in humans or first approval, as the technology record states it.
The founded year on company records.
Portland, OR